$18.28
-0.08-0.44%
At close: Feb 18, 4:00 PM EST
$18.28
N/A
After Hours: 4:00 PM EST
Comments
Loading...
Monte Rosa Therapeutics Inc Earnings Estimates
GLUENASDAQ
Monte Rosa Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:GLUE
Monte Rosa Therapeutics (GLUE) is scheduled to report Q4 earnings on March 19, 2026. Analysts estimate EPS of $-0.38 and quarterly revenue of $13.41M.
In the most recent quarter (Q3), Monte Rosa Therapeutics reported EPS of $-0.33, beating estimates of $-0.37 by 0.11%. Revenue came in at $12.77M, exceeding the estimate of $7.53M by 0.70%.
Monte Rosa Therapeutics has beaten EPS estimates in 7 consecutive quarters.
Over the last 4 quarters, Monte Rosa Therapeutics has averaged an EPS surprise of 1.27% and a revenue surprise of 2.84%.
Earnings Date
Mar 19
EPS Estimate
$-0.380
Quarterly Revenue Estimate
$13.41M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$181.54M
Monte Rosa Therapeutics Earnings History
Analyze the earnings history of Monte Rosa Therapeutics using advanced sorting and filters.
Monte Rosa Therapeutics (GLUE) Earnings Per Share
The chart below shows Monte Rosa Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $-0.33 | $-0.37 | 10.8 % |
| Q2 | 2025-08-07 | $-0.15 | $-0.34 | 55.9 % |
| Q1 | 2025-05-08 | $0.57 | $-0.32 | 278.1 % |
| Q4 | 2025-03-20 | $0.23 | $-0.37 | 162.2 % |
Monte Rosa Therapeutics (GLUE) Revenue
The chart below shows Monte Rosa Therapeutics's reported revenue compared to analyst estimates over recent quarters.
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-06 | $12.77M | $7.53M | 69.5 % |
| Q2 | 2025-08-07 | $23.19M | $8.68M | 167.3 % |
| Q1 | 2025-05-08 | $84.93M | $13.57M | 525.9 % |
| Q4 | 2025-03-20 | $60.65M | $12.79M | 374.2 % |
FAQ
When is Monte Rosa Therapeutics (NASDAQ:GLUE) reporting earnings?
Monte Rosa Therapeutics (GLUE) is scheduled to report earnings on May 7, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.
What were the latest earnings per share (EPS) for Monte Rosa Therapeutics (NASDAQ:GLUE)?
The Actual EPS was $-0.33, which beat the estimate of $-0.37.
What were Monte Rosa Therapeutics’s (NASDAQ:GLUE) revenues?
The Actual Revenue was $12.77M, which beat the estimate of $7.53M.
